semaglutide side effects depression Ozempic | Ozempic type 2 diabetes injection Penn study focuses on semaglutide

GLP-1 receptor agonists: a clinical perspective on cardiovascular effects

A., Durand T., Ejsing C

Recent Chinese Phase III clinical studies have confirmed that the GLP-1/GCG dual receptor agonist Mazdutide is more effective than Dulaglutide in terms of blood glucose control and weight loss, while also improving multiple cardiometabolic, liver, and kidney-related indicators

The reactions are documented in animal models and reported anecdotally in human users

In these patients, especially those with heart or kidney disease, the drugs improved blood sugar control, reduced the risk of heart and kidney complications, supported weight loss, and lowered the risk of early death

Neurotoxicology 83 , 7788 (2021)